- Home
- RGNX vs VERI Comparison
RGNX vs VERI Comparison
Compare RGNX & VERI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- RGNX
- VERI
- Stock Information
- Founded
- RGNX 2008
- VERI 2014
- Country
- RGNX United States
- VERI United States
- Employees
- RGNX N/A
- VERI N/A
- Industry
- RGNX Biotechnology: Biological Products (No Diagnostic Substances)
- VERI EDP Services
- Sector
- RGNX Health Care
- VERI Technology
- Exchange
- RGNX Nasdaq
- VERI Nasdaq
- Market Cap
- RGNX 661.2M
- VERI 588.2M
- IPO Year
- RGNX 2015
- VERI 2017
- Fundamental
- Price
- RGNX $12.77
- VERI $6.26
- Analyst Decision
- RGNX Strong Buy
- VERI Strong Buy
- Analyst Count
- RGNX 7
- VERI 5
- Target Price
- RGNX $30.00
- VERI $10.40
- AVG Volume (30 Days)
- RGNX 601.4K
- VERI 10.3M
- Earning Date
- RGNX 11-06-2025
- VERI 11-06-2025
- Dividend Yield
- RGNX N/A
- VERI N/A
- EPS Growth
- RGNX N/A
- VERI N/A
- EPS
- RGNX N/A
- VERI N/A
- Revenue
- RGNX $155,782,000.00
- VERI $90,902,000.00
- Revenue This Year
- RGNX $198.02
- VERI $19.16
- Revenue Next Year
- RGNX $2.67
- VERI $18.82
- P/E Ratio
- RGNX N/A
- VERI N/A
- Revenue Growth
- RGNX 74.95
- VERI N/A
- 52 Week Low
- RGNX $5.04
- VERI $1.22
- 52 Week High
- RGNX $13.93
- VERI $9.42
- Technical
- Relative Strength Index (RSI)
- RGNX 58.75
- VERI 53.81
- Support Level
- RGNX $12.66
- VERI $5.90
- Resistance Level
- RGNX $13.93
- VERI $7.77
- Average True Range (ATR)
- RGNX 0.72
- VERI 0.74
- MACD
- RGNX -0.04
- VERI -0.09
- Stochastic Oscillator
- RGNX 61.82
- VERI 32.12
About RGNX REGENXBIO Inc.
Regenxbio Inc is a biotechnology company. Its main activity is the development and commercialization of recombinant adeno associated virus gene therapy to correct an underlying genetic defect. The diseases that the Regenxbio platform targets are metabolic (homozygous familial hypercholesterolemia), neurodegenerative conditions (mucopolysaccharidosis), and retinal diseases (wet age-related macular degeneration, X-linked retinitis pigmentosa). The company derives the majority of its revenue from the United States.
About VERI Veritone Inc.
Veritone Inc is a provider of artificial intelligence (AI) computing solutions and services. It generates revenue through the delivery of its Software Products and Services which consists of revenues generated from Commercial Enterprise and Government and Regulated Industries customers using the company's aiWARE platform and hiring solutions, any related support and maintenance services, and any related professional services associated with the deployment and/or implementation of such solutions, Managed Services which consist of revenues generated from Commercial Enterprise customers using company's content licensing services, advertising agency, influencer management and related services. It has a presence in the United States, the United Kingdom, France, Australia, Israel, and India.